Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan

Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vaccines exist such as HIV, dengue virus, Ebola virus and malaria, and for which more improved vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Yoshikazu, Aruga, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494244/
https://www.ncbi.nlm.nih.gov/pubmed/26344953
http://dx.doi.org/10.3390/vaccines3010186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494244/
https://www.ncbi.nlm.nih.gov/pubmed/26344953
http://dx.doi.org/10.3390/vaccines3010186

Ejemplares similares